Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 805 results for "daiichi sankyo company"

Daiichi Sankyo Q1 Profit, Revenue Up - Quick Facts

Pharmaceutical company Daiichi Sankyo Company Limited (DSKYF.PK) Friday said first-quarter profit attributable to owners of the company climbed to 34.9 billion yen from 21.6 billion yen in the comparable quarter last year. Operating profit was 49.1 ... RTTNews.com, 1 month ago

Daiichi Sankyo : Revision to 'Results Briefing (Results for Q1 FY2015)'

Release date- 31072015 - Tokyo, Japan - Daiichi Sankyo Company, Limited today announced a revision as follows to the 'Results Briefing (Results for Q1 FY2015)' materials originally disclosed at 1:00pm on Thursday , July 31, 2015 . Revised item ...
 4 Traders1 month ago Daiichi Sankyo acquires Ranbaxy in $4.6B deal  FierceBiotech1 month ago Daiichi Sankyo Announces Details of Executive Share Options  PharmiWeb1 month ago DAIICHI SANKYO : Announces Details of Executive Share Options  4 Traders1 month ago

Federal Circuit approves PTO's interim procedure on patent term adjustments

Digest of Daiichi Sankyo Company, LTD. v. Michelle K. Lee, Director, United States Patent and Trademark Office, No. 2014-1280 (Fed. Cir. July 2, 2015) (precedential). On appeal from D.D.C. Before Moore, Reyna , and Taranto. Procedural Posture : ...
 Lexology1 month ago
Sys-Con Media

Pieris to Get 7th Milestone Payment from Daiichi Sankyo Collaboration to Develop Anticalin Therapeutics [Professional Services Close - Up]

Pieris Pharmaceuticals recently reported it will receive its third milestone payment for the second program in its discovery and development collaboration with Daiichi Sankyo Company, Limited, and seventh milestone payment overall under the multi ...
 Pharmacy Choice1 month ago Pieris Pharmaceuticals Announces Closing of Over-Allotment Option in Public Offering of Common Stock  Fat Pitch Financials1 month ago Pieris Pharmaceuticals to Host Second Quarter 2015 Investor Call on August 13th  Sys-Con Canada1 month ago Pieris Pharmaceuticals Reports Financial Results for the Second Quarter Ended June 30, 2015  Sys-Con Media3 weeks ago
[x]  

Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences.

PRWeb Continuing Education Company (CEC) and Daiichi Sankyo Inc have awarded independent educational grants in support of an interaction simulation session entitled "NOACS: What the Evidence Shows in Managing AFib, Stroke Prevention and DVT/PE." ...
 Industrial Info Financials1 month ago PCI in ACS: Deciding Among Clopidogrel, Prasugrel, or Ticagrelor  Orthopedics Today1 month ago
[x]  

DAIICHI SANKYO : 13th Takamine Memorial Daiichi Sankyo Prize Winner Announced

Release date- 01072015 - Tokyo, Japan - Daiichi Sankyo Company, Limited today announced that its affiliated foundation, the Daiichi Sankyo Foundation of Life Science* (headquarters, Tokyo ; Chairman, Joji Nakayama ) has awarded its 13th Takamine ...
 4 Traders2 months ago 13th Takamine Memorial Daiichi Sankyo Prize Winner Announced  Pharmacy Times2 months ago

Daiichi Sankyo, Plexxikon Inc.'s Rare Disease Drug Shows Promise in Phase I Study

- Fifty-two percent of patients achieved a partial response and 30 percent of patients had stable disease following treatment with PLX3397, an investigational CSF-1R inhibitor - A rare tumor of the joint or tendon sheath, TGCT can lead to ...
 BioSpace1 month ago Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients  Vision Monday1 month ago
[x]  
Diagnostic & Invasive Cardiology

Daiichi Sankyo Release: Recommends Once-daily LIXIANA (edoxaban) For The Treatment And Prevention Of Recurrent Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) In Adults

/PRNewswire/ -- NICE Final Appraisal Determination recommends that edoxaban is a cost effective use of NHS resources The National Institute for Health and Care Excellence (NICE) has recommended a new treatment to help patients ...
 BioSpace1 month ago U.K. Agency Recommends Edoxaban for Deep Vein Thrombosis, Pulmonary Embolism  Diagnostic & Invasive Cardiology3 weeks ago NICE recommends once-daily LIXIANA for preventing stroke and systemic embolism  GM Journal4 weeks ago NICE recommends new treatment for blood clots  GM Journal1 month ago
[x]  

Compliance - Hear from CCO from Lundbeck, Daiichi Sankyo and Novartis

With tightening transparency requirements the pharmaceutical industry is under increasing pressure to ensure fully compliant communication and interactions through all areas of their business functions. How can you evolve current business practices ...
 News-Medical.Net1 month ago

Daiichi Sankyo Release: New Therapy To Help Heart Rhythm Patients Means Doctors Are "Spoilt For Choice" 7/10/2015

/PRNewswire/ -- Launch comes as new patients' survey reveals a significant proportion still not receiving adequate treatment for atrial fibrillation, the commonest heart rhythm disorder A new blood-thinning drug therapy to help ...
 ClinicSpace1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - daiichi sankyo company
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less